Podcasts-Episode#3 - Applied Clinical Trials

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search

ADVERTISEMENT

Find Pharma Search Engine
   Printer friendly page
Podcasts-Episode#3
ACT Podcast Series
logo
spacer
 parksState & Direction of Drug
Development for Diabetes - Part 1
Dr. Mary Parks
Director, Division of Metabolism and Endocrinology Products
FDA Center for Drug Evaluation and Research
 
spacer
line
spacer
ACT Podcast Interview Subscribe to the Podcast
spacer
Interview: Dr. Parks is the current Director of the Division of Metabolism and Endocrinology Products at FDA’s Center for Drug Evaluation and Research (CDER) and a board-certified endocrinologist and internist who holds a faculty appointment at Georgetown University Medical Center. The largest of FDA’s five centers, CDER is responsible for reviewing and evaluating sponsors’ new drug applications (NDAs) for both prescription and over-the-counter drugs.

Listen to Applied Clinical Trials? Managing Editor Kerri Nelen interview Dr. Parks about the State and Direction of Drug Development for Diabetes.

In this podcast, Dr. Parks discusses the current challenges diabetes trials pose for sponsors, the types of meetings sponsors of diabetes trials are having with CDER, and the kinds of advice the agency is providing them in terms of safety and efficacy.		 
Click on the RSS Icon to subscribe to all ACT podcasts with your installed reader.
rss
If you don't have an RSS reader installed yet, here are some options:
itunes
yahoo
google
spacer
To learn more about CDER - CLICK HERE

line
spacer
Return to Main Podcast Page
spacer
line
Applied Clinical Trials podcasts are developed and produced by ACTMAGAZINE.COM, a division of Advanstar Communications, Inc., which is solely responsible for podcast content.

ADVERTISEMENT

ADVERTISEMENT

Click here